REGENERON PHARMACEUTICALS, INC. (REGN)
Pharmaceutical Preparations · Healthcare · $58.0B
Intrinsic Value (Consensus)
$669.37
Current Price
$614.73
Margin of Safety
+8.9%
8.9% Below Intrinsic Value
Value: $669
Price: $615
Valuation Model Estimates
Current Price: $614.73
DCF (Discounted Cash Flow)
$889.30
Graham Number
$555.87
Earnings Power Value
$402.72
Relative Value (P/E)
$829.60
Dividend Discount Model
$44.55
Consensus Value
$669.37
Model Assumptions
Discount Rate
10.3%
Growth Rate
8.2%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
67
Profitability
18/25
Strength
24/25
Valuation
15/25
Growth
10/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $41.48
- EPS (Forward)
- $44.88
- Book Value
- $331.07
- P/E Ratio
- 20.0
- Forward P/E
- 18.5
- PEG Ratio
- —
- ROE
- 14.4%
- Debt/Equity
- 6%
- Revenue Growth
- 1.0%
- Earnings Growth
- 8.2%
- Dividend Yield
- 0.1%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance